ACE2 and COVID-19: Various etiopathogenetic hypotheses have been advanced to explain the occurrence of diarrhea in COVID-19 patients, including loss in enterocyte absorption capability, microscopic mucosal inflammation damage, and an impaired function of ACE2, which leads to a downstream dysbiosis and metabolite imbalance [52–56].